PA
PFE icon

Prossimo Advisors’s Pfizer PFE Stock Holding History

Prossimo Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,046
Closed -$305K – 139
2025
Q1 		$305K Sell
12,046
-786
-6% -$20.6K 0.23% 108
2024
Q4 		$340K Buy
12,832
+4
+0% +$108 0.25% 107
2024
Q3 		$371K Sell
12,828
-11,421
-47% -$333K 0.27% 106
2024
Q2 		$678K Buy
+24,249
New +$668K 0.61% 51
2023
Q3 		– Sell
-31,042
Closed -$1.14M – 103
2023
Q2 		$1.14M Buy
+31,042
New +$1.21M 1.1% 19

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Prossimo Advisors's PFE Position: Q2 2025 in Review

Prossimo Advisors sold out of Pfizer (PFE) in Q2 2025, closing a stake of 12,046 shares — an estimated $305K sold.

Prossimo Advisors first reported a position in PFE in Q2 2023 and held it in 5 quarters. The position peaked at $1.14M in Q2 2023. 2,810 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Prossimo Advisors reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Prossimo Advisors sold 12,046 Pfizer shares in Q2 2025, an estimated $305K.
  • Prossimo Advisors first reported a position in Pfizer in Q2 2023 and held it in 5 quarters.
  • Prossimo Advisors's Pfizer position peaked at $1.14M in Q2 2023.
  • 2,810 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Prossimo Advisors's 13F filing for Q2 2025, filed 13 Aug 2025.